M. Nilsson

Effect of the monoaminergic stabiliser (−)-OSU6162 on mental fatigue following stroke or traumatic brain injury

R. Schuit, L. Rönnbäck, B. Johansson, 2020, Acta Neuropsychiatrica.

Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse

M. Carlsson, M. Nilsson, Katarina Rydén Markinhuhta, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice

A. Carlsson, M. Carlsson, M. Nilsson, 2007, Neuroscience.

Schizophrenia: from dopamine to glutamate and back.

A. Carlsson, M. Carlsson, M. Nilsson, 2004, Current medicinal chemistry.

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice

A. Carlsson, P. Martin, M. Carlsson, 1999, Journal of Neural Transmission.

The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice

M. Carlsson, M. Nilsson, 2005, Journal of Neural Transmission.

Glycine and D-serine decrease MK-801-induced hyperactivity in mice

A. Carlsson, M. Carlsson, M. Nilsson, 2005, Journal of Neural Transmission.

A behavioural pattern analysis of hypoglutamatergic mice – effects of four different antipsychotic agents

A. Carlsson, M. Carlsson, N. Waters, 2001, Journal of Neural Transmission.

The monoaminergic stabilizer (−)-OSU6162 reverses delay-dependent natural forgetting and improves memory impairment induced by scopolamine in mice

M. Carlsson, M. Nilsson, 2013, Neuropharmacology.

The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition

A. Carlsson, F. Pettersson, M. Carlsson, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.